Trial reportScientific reports2026
Physical therapy using digital therapeutics in infants with congenital muscular torticollis: a pilot study.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Congenital muscular torticollis (CMT) is a common musculoskeletal problem associated with unilateral sternocleidomastoid muscle stiffness. We evaluated the feasibility of the newly developed digital therapeutics (DTx) ACESO-APP, a personalized exercise app with real-time feedback, using skeleton-based motion analysis and artificial intelligence-driven body reconstruction models. Fourteen participants were randomized to undergo either weekly PT with standard home program education (SE group) or weekly PT with digital therapeutics lead home program (DTx group). A 12-week home exercise program (HEP) comprising stretching exercises was encouraged in both groups with weekly in-hospital PT. Clinical changes were assessed using the torticollis overall assessment at 4, 8, and 12 weeks, and participants' HEP adherence over 1 week was assessed using a questionnaire. Recruitment and completion rates, adherence rate, System Usability Scale scores, and adverse events were summarized using descriptive statistics. Eight participants (4 in each group) completed the study. The overall recruitment rate was approximately 5.2 participants per month, and the completion rate was 57.1% for both groups. The DTx group demonstrated higher adherence, with no reported adverse events. ACESO-APP demonstrated feasibility but achieved a suboptimal completion rate. These preliminary findings support large-scale trials and further optimization of HEP using the ACESO-APP in children with CMT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.